Advertisement

Meta-Analysis Comparing Fractional Flow Reserve and Angiography-Guided Complete Revascularization of Nonculprit Artery for ST-Elevation Myocardial Infarction

Published:September 14, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.08.005
      This study aimed to compare complete revascularization (CR) guided by angiography with a fractional flow reserve (FFR)-guided strategy in patients presenting with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD). CR is preferred to culprit-only revascularization for patients with STEMI and MVD. However, whether FFR-guided CR is superior to angiography-guided CR is unclear in patients presenting with STEMI who have MVD. Randomized controlled trials comparing CR with an FFR- or angiography-guided strategy to culprit-only revascularization in patients with STEMI and MVD were systematically identified. A random-effects network meta-analysis was performed comparing clinical outcomes in the 3 arms. A total of 13 studies with a total of 8,927 patients were included in our analysis. Compared with culprit-only revascularization, angiography-guided CR was associated with a significantly decreased risk of myocardial infarction (MI) (hazard ratio [HR] 0.55, 95% confidence interval [CI] 0.37 to 0.82), all-cause death (HR 0.69, 95% CI 0.49 to 0.97), and cardiovascular death (HR 0.54, 95% CI 0.34 to 0.85) but FFR-guided CR was not (MI: HR 0.77, 95% CI 0.53 to 1.12; cardiovascular death: HR 0.89, 95% CI 0.64 to 1.24; all-cause death: HR 0.93, 95% CI 0.72 to 1.18). The network meta-analysis comparison of angiography- versus FFR-guided CR showed an HR of 0.75 (95% CI 0.50 to 1.11) for all-cause death and an HR of 0.71 (95% CI 0.54 to 1.17) for MI. In conclusion, for patients with MVD presenting with STEMI, angiography-guided CR may provide additional benefits compared with FFR-guided CR.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Keeley EC
        • Boura JA
        • Grines CL.
        Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
        Lancet. 2003; 361: 13-20
        • Sorajja P
        • Gersh BJ
        • Cox DA
        • McLaughlin MG
        • Zimetbaum P
        • Costantini C
        • Stuckey T
        • Tcheng JE
        • Mehran R
        • Lansky AJ
        • Grines CL
        • Stone GW.
        Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
        Eur Heart J. 2007; 28: 1709-1716
        • Saito Y
        • Kobayashi Y.
        Percutaneous coronary intervention strategies in patients with acute myocardial infarction and multivessel disease: completeness, timing, lesion assessment, and patient status.
        J Cardiol. 2019; 74: 95-101
        • Lawton JS
        • Tamis-Holland JE
        • Bangalore S
        • Bates ER
        • Beckie TM
        • Bischoff JM
        • Bittl JA
        • Cohen MG
        • DiMaio JM
        • Don CW
        • Fremes SE
        • Gaudino MF
        • Goldberger ZD
        • Grant MC
        • Jaswal JB
        • Kurlansky PA
        • Mehran R
        • Metkus Jr, TS
        • Nnacheta LC
        • Rao SV
        • Sellke FW
        • Sharma G
        • Yong CM
        • Zwischenberger BA
        • Writing Committee Members
        2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol 2022;79:1547].
        J Am Coll Cardiol. 2022; 79: e21-e129
        • Mehta SR
        • Wood DA
        • Storey RF
        • Mehran R
        • Bainey KR
        • Nguyen H
        • Meeks B
        • Di Pasquale G
        • López-Sendón J
        • Faxon DP
        • Mauri L
        • Rao SV
        • Feldman L
        • Steg PG
        • Avezum Á
        • Sheth T
        • Pinilla-Echeverri N
        • Moreno R
        • Campo G
        • Wrigley B
        • Kedev S
        • Sutton A
        • Oliver R
        • Rodés-Cabau J
        • Stanković G
        • Welsh R
        • Lavi S
        • Cantor WJ
        • Wang J
        • Nakamya J
        • Bangdiwala SI
        • Cairns JA
        • COMPLETE Trial Steering Committee and Investigators
        Complete revascularization with multivessel PCI for myocardial infarction.
        N Engl J Med. 2019; 381: 1411-1421
        • Ahmad Y
        • Howard JP
        • Arnold A
        • Prasad M
        • Seligman H
        • Cook CM
        • Warisawa T
        • Shun-Shun M
        • Ali Z
        • Parikh MA
        • Al-Lamee R
        • Sen S
        • Francis D
        • Moses JW
        • Leon MB
        • Stone GW
        • Karmpaliotis D
        Complete revascularization by percutaneous coronary intervention for patients with ST-segment-elevation myocardial infarction and multivessel coronary artery disease: an updated meta-analysis of randomized trials.
        J Am Heart Assoc. 2020; 9e015263
        • Wald DS
        • Hadyanto S
        • Bestwick JP.
        Should fractional flow reserve follow angiographic visual inspection to guide preventive percutaneous coronary intervention in ST-elevation myocardial infarction?.
        Eur Heart J Qual Care Clin Outcomes. 2020; 6: 186-192
        • Elgendy IY
        • Mahmoud AN
        • Kumbhani DJ
        • Bhatt DL
        • Bavry AA.
        Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials.
        JACC Cardiovasc Interv. 2017; 10: 315-324
        • Puymirat E
        • Cayla G
        • Simon T
        • Steg PG
        • Montalescot G
        • Durand-Zaleski I
        • le Bras A
        • Gallet R
        • Khalife K
        • Morelle JF
        • Motreff P
        • Lemesle G
        • Dillinger JG
        • Lhermusier T
        • Silvain J
        • Roule V
        • Labèque JN
        • Rangé G
        • Ducrocq G
        • Cottin Y
        • Blanchard D
        • Charles Nelson A
        • De Bruyne B
        • Chatellier G
        Danchin N, FLOWER-MI Study Investigators. Multivessel PCI guided by FFR or angiography for myocardial infarction.
        N Engl J Med. 2021; 385: 297-308
        • Liberati A
        • Altman DG
        • Tetzlaff J
        • Mulrow C
        • Gøtzsche PC
        • Ioannidis JP
        • Clarke M
        • Devereaux PJ
        • Kleijnen J
        • Moher D.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
        J Clin Epidemiol. 2009; 62: e1-e34
        • Higgins JPT
        • Altman DG
        • Gøtzsche PC
        • Jüni P
        • Moher D
        • Oxman AD
        • Savović J
        • Schulz KF
        • Weeks L
        • Sterne JAC
        • Cochrane Bias Methods Group, Cochrane Statistical Methods Group
        The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
        BMJ. 2011; 343: d5928
        • Egger M
        • Davey Smith GD
        • Schneider M
        • Minder C
        Bias in meta-analysis detected by a simple, graphical test.
        BMJ. 1997; 315: 629-634
        • Neupane B
        • Richer D
        • Bonner AJ
        • Kibret T
        • Beyene J.
        Network meta-analysis using R: a review of currently available automated packages.
        PLoS One. 2014; 9e115065
        • Di Mario C
        • Mara S
        • Flavio A
        • Imad S
        • Antonio M
        • Anna P
        • Emanuela P
        • Stefano DS
        • Angelo R
        • Stefania C
        • Anna F
        • Carmelo C
        • Antonio C
        • Monzini N
        • Bonardi MA
        Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for acute myocardial infarction (HELP AMI) Study.
        Int J Cardiovasc Intervent. 2004; 6: 128-133
        • Engstrøm T
        • Kelbæk H
        • Helqvist S
        • Høfsten DE
        • Kløvgaard L
        • Holmvang L
        • Jørgensen E
        • Pedersen F
        • Saunamäki K
        • Clemmensen P
        • De Backer O
        • Ravkilde J
        • Tilsted HH
        • Villadsen AB
        • Aarøe J
        • Jensen SE
        • Raungaard B
        • Køber L
        DANAMI-3—PRIMULTI Investigators. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
        Lancet. 2015; 386: 665-671
        • Gershlick AH
        • Khan JN
        • Kelly DJ
        • Greenwood JP
        • Sasikaran T
        • Curzen N
        • Blackman DJ
        • Dalby M
        • Fairbrother KL
        • Banya W
        • Wang D
        • Flather M
        • Hetherington SL
        • Kelion AD
        • Talwar S
        • Gunning M
        • Hall R
        • Swanton H
        • McCann GP.
        Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
        J Am Coll Cardiol. 2015; 65: 963-972
        • Ghani A
        • Dambrink JH
        • van 't Hof AW
        • Ottervanger JP
        • Gosselink AT
        • Hoorntje JC.
        Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial.
        Neth Heart J. 2012; 20: 347-353
        • Hamza M
        • Mahmoud N
        • Elgendy IY.
        A randomized trial of complete Versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease.
        J Interv Cardiol. 2016; 29: 241-247
        • Politi L
        • Sgura F
        • Rossi R
        • Monopoli D
        • Guerri E
        • Leuzzi C
        • Bursi F
        • Sangiorgi GM
        • Modena MG.
        A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up.
        Heart. 2010; 96: 662-667
        • Smits PC
        • Abdel-Wahab M
        • Neumann FJ
        • Boxma-de Klerk BM
        • Lunde K
        • Schotborgh CE
        • Piroth Z
        • Horak D
        • Wlodarczak A
        • Ong PJ
        • Hambrecht R
        • Angerås O
        • Richardt G
        • Omerovic E
        Compare-Acute Investigators. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction.
        N Engl J Med. 2017; 376: 1234-1244
        • Wald DS
        • Morris JK
        • Wald NJ
        • Chase AJ
        • Edwards RJ
        • Hughes LO
        • Berry C
        • Oldroyd KG
        • Investigators PRAMI
        Randomized trial of preventive angioplasty in myocardial infarction.
        N Engl J Med. 2013; 369: 1115-1123
      1. Hlinomaz O. Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy (PRAGUE 13 trial) Euro PCR. Available at:https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi7paGN6tX5AhVfxXMBHRwlBVgQFnoECAIQAQ&url=https%3A%2F%2Fmedia.pcronline.com%2Fdiapos%2FEuroPCR2015%2F2173-20150519_1445_Main_Arena_Hlinomaz_Ota_1111_(6859)%2FHlinomaz_Ota_20150519_1445_Main_Arena.pdf&usg=AOvVaw0KJYZHHFnEk0Fo-WiDz8pw. Accessed on December 21, 2021

        • Zhang J
        • Wang Q
        • Yang H
        • Ma L
        • Fu X
        • Hou W
        • Feng J
        • Liu X.
        Evaluation of different revascularization strategies for patients with acute myocardial infarction with lesions of multiple coronary arteries after primary percutaneous coronary intervention and its economic evaluation.
        Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015; 27: 169-174
        • Calviño-Santos R
        • Estévez-Loureiro R
        • Peteiro-Vázquez J
        • Salgado-Fernández J
        • Rodríguez-Vilela A
        • Franco-Gutiérrez R
        • Bouzas-Mosquera A
        • Rodríguez-Fernández JÁ
        • Mesías-Prego A
        • González-Juanatey C
        • Aldama-López G
        • Piñón-Esteban P
        • Flores-Ríos X
        • Soler-Martín R
        • Seoane-Pillado T
        • Vázquez-González N
        • Muñiz J
        • Vázquez-Rodríguez JM.
        Angiographically guided complete revascularization Versus selective stress echocardiography-guided revascularization in patients with ST-segment-elevation myocardial infarction and multivessel disease: the CROSS-AMI randomized clinical trial.
        Circ Cardiovasc Interv. 2019; (12e007924)
        • Tarasov RS
        • Ganyukov VI
        • Barbarash OL
        • Barbarash LS.
        Two preventive multivessel stenting strategy with zotarolimus eluting stents in STelevation myocardial infarction patients: 12-month results of randomized trial.
        Interv Cardiol. 2017; 9: 57-63
        • Ochala A
        • Smolka GA
        • Wojakowski W
        • Dudek D
        • Dziewierz A
        • Krolikowski Z
        • Gasior Z
        • Tendera M.
        The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction.
        J Invasive Cardiol. 2004; 16: 699-702
        • Bainey KR
        • Engstrøm T
        • Smits PC
        • Gershlick AH
        • James SK
        • Storey RF
        • Wood DA
        • Mehran R
        • Cairns JA
        • Mehta SR.
        Complete vs culprit-lesion-only revascularization for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
        JAMA Cardiol. 2020; 5: 881-888
        • Pavasini R
        • Biscaglia S
        • Barbato E
        • Tebaldi M
        • Dudek D
        • Escaned J
        • Casella G
        • Santarelli A
        • Guiducci V
        • Gutierrez-Ibanes E
        • Di Pasquale G
        • Politi L
        • Saglietto A
        • D'Ascenzo F
        • Campo G
        Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
        Eur Heart J. 2020; 41: 4103-4110
        • Pasceri V
        • Patti G
        • Pelliccia F
        • Gaudio C
        • Speciale G
        • Mehran R
        • Dangas GD.
        Complete revascularization during primary percutaneous coronary intervention reduces death and myocardial infarction in patients With multivessel disease: meta-analysis and meta-regression of randomized trials.
        JACC Cardiovasc Intv. 2018; 11: 833-843
        • Pinilla-Echeverri N
        • Mehta SR
        • Wang J
        • Lavi S
        • Schampaert E
        • Cantor WJ
        • Bainey KR
        • Welsh RC
        • Kassam S
        • Mehran R
        • Storey RF
        • Nguyen H
        • Meeks B
        • Wood DA
        • Cairns JA
        • Sheth T.
        Nonculprit lesion plaque morphology in patients with ST-segment-elevation myocardial infarction: results from the COMPLETE trial optical coherence tomography Substudys.
        Circ Cardiovasc Interv. 2020; 13e008768
        • Moroni F
        • Gallone G
        • Baldetti L.
        Completing the job: the advantage of complete revascularization in ST-elevation myocardial infarction over culprit-only revascularization strategies.
        Int J Cardiol Heart Vasc. 2020; 27100491
        • Fang C
        • Yin Y
        • Jiang S
        • Zhang S
        • Wang J
        • Wang Y
        • Li L
        • Wang Y
        • Guo J
        • Yu H
        • Wei G
        • Lei F
        • Chen T
        • Ren X
        • Tan J
        • Xing L
        • Hou J
        • Dai J
        • Yu B.
        Increased vulnerability and distinct layered phenotype at culprit and nonculprit lesions in STEMI Versus NSTEMI.
        JACC Cardiovasc Imaging. 2022; 15: 672-681
        • Reed GW
        • Rossi JE
        • Cannon CP.
        Acute myocardial infarction.
        Lancet. 2017; 389: 197-210
        • Thim T
        • van der Hoeven NW
        • Musto C
        • Nijveldt R
        • Götberg M
        • Engstrøm T
        • Smits PC
        • Oldroyd KG
        • Gershlick AH
        • Escaned J
        • Baptista SB
        • Raposo L
        • van Royen N
        • Maeng M.
        Evaluation and management of nonculprit lesions in STEMI.
        JACC Cardiovasc Interv. 2020; 13: 1145-1154
        • van de Hoef TP
        • Nolte F
        • Echavarría-Pinto M
        • van Lavieren MA
        • Damman P
        • Chamuleau AJ S
        • Voskuil M
        • Verberne HJ
        • Henriques JPS
        • van Eck-Smit BLF
        • Koch KT
        • de Winter RJ
        • Spaan JAE
        • Siebes M
        • Tijssen JGP
        • Meuwissen M
        • Piek JJ.
        Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment.
        Heart. 2014; 100: 951
        • de Waard GA
        • Hollander MR
        • Teunissen PF
        • Jansen MF
        • Eerenberg ES
        • Beek AM
        • Marques KM
        • van de Ven PM
        • Garrelds IM
        • Danser AH
        • Duncker DJ
        • van Royen N
        Changes in Coronary Blood Flow After Acute Myocardial Infarction: Insights From a Patient Study and an Experimental Porcine Model.
        JACC Cardiovasc Interv. 2016; 9: 602-613
        • van der Hoeven NW
        • Janssens GN
        • de Waard GA
        • Everaars H
        • Broyd CJ
        • Beijnink CWH
        • van de Ven PM
        • Nijveldt R
        • Cook CM
        • Petraco R
        • ten Cate T
        • von Birgelen C
        • Escaned J
        • Davies JE
        • van Leeuwen MAH
        • van Royen N
        Temporal changes in coronary hyperemic and resting hemodynamic indices in nonculprit vessels of patients with ST-segment elevation myocardial infarction.
        JAMA Cardiol. 2019; 4: 736-744